Integra LifeSciences Cor...

NASDAQ: IART · Real-Time Price · USD
14.23
0.61 (4.48%)
At close: Aug 15, 2025, 3:45 PM

Integra LifeSciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
246.38M 276.4M 456.66M 513.45M
Short-Term Investments
27.19M 32.69M 16.68M n/a
Long-Term Investments
n/a 30.71M 567.34M 6.48M
Other Long-Term Assets
66.52M 27.48M -510.15M 9.96M
Receivables
272.37M 259.33M 263.46M 231.83M
Inventory
429.09M 389.61M 324.58M 317.39M
Other Current Assets
29.65M 32.64M 31.03M n/a
Total Current Assets
1.08B 1.06B 1.16B 1.15B
Property-Plant & Equipment
549.76M 496.38M 459.59M 396.25M
Goodwill & Intangibles
2.3B 2.12B 2.17B 2.16B
Total Long-Term Assets
2.96B 2.72B 2.73B 2.63B
Total Assets
4.04B 3.78B 3.89B 3.78B
Account Payables
82.5M 92.33M 102.1M 61.84M
Deferred Revenue
n/a 8.54M 7.25M 5.29M
Short-Term Debt
607.08M 14.53M 52.75M 59.77M
Other Current Liabilities
232.55M 100.84M 65.41M 105.68M
Total Current Liabilities
922.13M 306.98M 320.91M 340.02M
Long-Term Debt
1.2B 1.49B 1.41B 1.5B
Other Long-Term Liabilities
313.17M 192.24M 138.5M 120.26M
Total Long-Term Liabilities
1.57B 1.89B 1.76B 1.76B
Total Liabilities
2.49B 2.19B 2.09B 2.1B
Total Debt
1.98B 1.68B 1.62B 1.65B
Common Stock
916K 909K 905K 896K
Retained Earnings
939.91M 946.86M 879.12M 698.57M
Comprehensive Income
-27.57M -15.11M 10.27M -45.16M
Shareholders Equity
1.55B 1.59B 1.8B 1.68B
Total Investments
27.19M 64.87M 567.34M 6.48M